Nicola Iacomino
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A fluorinated Janus-type dendrimer as an ionizable one-component nanocarrier for nucleic acids.
Journal: Nanoscale
Published: October 27, 2025
Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis: A New Mechanism of Action Beyond IgG Reduction.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 31, 2025
Therapeutic inhibition of telomeric DNA damage response rescues hematopoietic dysfunction driven by telomere shortening and aging.
Journal: Nature aging
Published: June 10, 2025
Baricitinib and Lonafarnib Synergistically Target Progerin and Inflammation, Improving Lifespan and Health in Progeria Mice.
Journal: International journal of molecular sciences
Published: April 12, 2025
Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine.
Journal: Cells
Published: August 07, 2024
COVID-19, Epstein-Barr virus reactivation and autoimmunity: Casual or causal liaisons?
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: June 27, 2024
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence.
Journal: Nature cell biology
Published: December 17, 2021
The Link between VAPB Loss of Function and Amyotrophic Lateral Sclerosis.
Journal: Cells
Published: June 25, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026